Beatriz M. Carreno

California University of Pennsylvania — United States

Immunology and Microbiology · Life Sciences

45h-index20.2kcitations137works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(59), Immune Cell Function and Interaction(48), T-cell and B-cell Immunology(46), CAR-T cell therapy research(33), Cancer Immunotherapy and Biomarkers(29)

Publications137 total

“Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8 <sup>+</sup> T cell recognition via mitochondrial neoantigen presentation”
2026Open Access
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
Cancer Cell·2025
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2025Open Access
Tumor Associated Mitochondria Antigens (TAMAs) vaccine is effective on tumor and tumor associated endothelial cells: from the mechanisms to the clinical validation 3298
The Journal of Immunology·2025Open Access
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
Cancer Cell·2025· 14 cited
LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma
Scientific Reports·2025Open Access
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Cancer Cell·2025· 37 cited
Antigen-Specific Profiling Identifies T-bet-Expressing Melanoma-Specific CD8 T Cells Associated with Pathologic Response to Neoadjuvant Anti-PD-1
SSRN Electronic Journal·2025· 1 citedOpen Access
EZH1/2 Inhibition Improves the Anti-Tumor Efficacy of CAR and TCR T-Cell Based Therapies Against Multiple Liquid and Solid Tumors
Blood·2024
398 Functional characterization of a class I-restricted CD8+ T cell receptor specific for the stem cell transcription factor Sox2
Regular and Young Investigator Award Abstracts·2024Open Access
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Journal of Clinical Investigation·2024· 15 citedOpen Access
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
Science Immunology·2024· 41 citedOpen Access
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations
Clinical Cancer Research·2024· 12 citedOpen Access
A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy
Molecular Therapy·2023· 13 citedOpen Access
Disinhibition of T Cell Activation Via CD5 Knockout Is a Universal Strategy to Enhance Adoptive T Cell Immunotherapies
Blood·2023· 2 cited
Aplastic Anemia Patients Have Diverse T Cell Repertoires and Flexible T Cell Responses Similar to Healthy Individuals
Blood·2023Open Access
407 Tumor associated mitochondria antigens (TAMAs) as target for cancer vaccine: from the mechanisms to the clinical validation
Regular and Young Investigator Award Abstracts·2023Open Access
Abstract PR08: TCR1020 specific for KRAS G12V restricted to HLA-A*11:01 exhibits potent and precise antigen specificity for clinical development
Molecular Cancer Research·2023
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023Open Access
Data from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Mary Collins(13), Gerald P. Linette(13), Vincent Ling(8), Carl H. June(8), Deborah Luxenberg(8), Ted H. Hansen(8), Miren L. Baroja(7), Laura Carter(5), Michelle Becker‐Hapak(5), Bruce L. Levine(4), Jasreet Hundal(4), Frann Bennett(4), Thu Chau(4), Joaquı́n Madrenas(4), Chong Xu(4), Joyce C. Solheim(4), Yoshiko Iwai(3), Hiroyuki Nishimura(3), Lori Fitz(3), Clive R. Wood(3)